04:51 PM EST, 11/07/2025 (MT Newswires) -- Cellectis ( CLLS ) reported Q3 earnings late Friday of $0.01 per diluted share, swinging from a loss of $0.23 a year earlier.

Analysts polled by FactSet expected a loss of $0.23.

Revenue and other income for the quarter ended Sept. 30 was $37.2 million, up from $18.1 million a year earlier.

Analysts surveyed by FactSet expected $9.6 million, if comparable.